Re:New treatment destroys head and neck cancer tumours in trial
by philjohn on Tuesday October 12, 2021 @06:24AM
(#28838085)
Someone I know was fortunate enough to get onto one of the clinical trials for ipilimumab - he had Malignant Melanoma that had spread to a nearby organ.
He's still alive 15 years later, despite the survivability for Melanoma that has spread is dire. That's, of course, a single piece of anecdata, but the power of biologicals in how we treat disease going forward cannot be understated.
Re:New treatment destroys head and neck cancer tumours in trial
by mrosett on Tuesday October 12, 2021 @10:51PM
(#28847696)
Sounds familiar: I had a one-in-four chance of surviving melanoma before I enrolled in a trial of ipilimumab 11 years ago. It really was an amazing breakthrough.
Re:New treatment destroys head and neck cancer tumours in trial
by testfoobar on Monday October 11, 2021 @12:51PM
(#28830325)
"Cancer breakthrough" / "Cure for cancer" stories must have very high click-thru rates due to the frequency we see them.
Note that the actual trial referenced by this article, CheckMate-651, failed its primary endpoint [1]. The positive result is only for a subpopulation of patients with high expression of one of the targeted proteins.
Anyway, if you haven't heard about immunooncology, it really is an amazing field with lots of great results. But this particular article about very incremental work.
[1]: https://www.onclive.com/view/nivolumab-ipilimumab-misses-os-...